Showing 2661-2670 of 20410 results for "".
Octane Aesthetics Tech Forum: Artificial Intelligence’s Expanding Role in Aesthetic Medicine
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-artificial-intelligences-expanding-role-in-aesthetic-medicine/54705/Jessica Wu, MD, Dermatologist, Author, and Founder & CEO of Residen, offers a grounded perspective on AI in aesthetics moving beyond hype to real-world application. She shares how AI is influencing clinical decision-making, where it is delivering measurable value in practice, and which emergingNutrition and Acne: Evidence-Based Insights for Smarter Dietary Guidance
https://reachmd.com/programs/clinicians-roundtable/nutrition-acne-evidence-based-guidance/49090/Many patients turn to dietary changes before ever filling a prescription for acne. But which interventions actually make a difference? To find out, Dr. John Barbieri breaks down the evidence behind nutrition’s role in acne. From low-glycemic diets and vitamin D to omega-3s and zinc, he highlights prAddressing Itch in Prurigo Nodularis Clinical Trials
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37170/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, addresses how future prurigo nodularis trials could better address the heterogeneity in disease burden and patient-reported outcomes.Evaluating Structured Interventions for Cognitive Support in MS
https://reachmd.com/programs/Audioabstracts/structured-interventions-cognitive-support-ms/54242/For patients with multiple sclerosis (MS), cognitive impairment can quietly erode independence and quality of life. In this AudioAbstract, Dr. Hallie Blevins discusses a head-to-head comparison of cognitive training, aerobic exercise, and a combined approach and explores how we can better support coExpert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
https://reachmd.com/programs/medical-industry-feature/igan-high-risk-progression-characteristics/39256/In patients with IgA nephropathy (IgAN), pathological findings can help provide important prognostic information beyond clinical context. Drs Dana Rizk, Sanjeev Sethi, Leal C. Herlitz, and Carla Nester provide expert insights on integrating these findings with clinical and demographic data to assessUnderstanding the Growing Impacts of Obesity on Patient Outcomes and Care Delivery
https://reachmd.com/programs/clinicians-roundtable/understanding-the-growing-impacts-of-obesity-patient-outcomes-and-care-delivery/39652/With obesity rates rising to unprecedented levels, clinicians face critical challenges in managing associated complications. Hear from Dr. Sujith Cherian as he explores obesity’s systemic impact, from cardiovascular and infectious risks to medication dosing and hospital care complexities. Dr.Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
https://reachmd.com/programs/project-oncology/immunotherapy-advances-in-early-stage-upper-gi-cancers/35503/Early-stage upper GI cancers carry a high risk of systemic spread, prompting a shift from conventional therapies to immunotherapy-based strategies. Given this evolving landscape, Dr. Ronan Kelly joins Dr. Jennifer Caudle to review landmark trials, including CheckMate 577 and MATTERHORN. Together, thObesity and Respiratory Function: Understanding Mechanical and Functional Impacts
https://reachmd.com/programs/clinicians-roundtable/obesity-and-respiratory-function-understanding-mechanical-and-functional-impacts/35661/Obesity impacts how the lungs function in a variety of ways, and understanding these impacts is essential for interpreting pulmonary function tests, identifying restrictive or obstructive patterns, and managing ventilation. Learn more with Dr. Sujith Cherian, who's an Associate Professor in the DiviEvaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
https://reachmd.com/programs/eye-on-ocular-health/evaluating-eyelid-wipes-for-dry-eye-disease-clinical-trial-insights/37276/A recent study presented at the 2025 American Academy of Ophthalmology Annual Meeting evaluated a novel treatment option for dry eye disease: a TRPM8 agonist delivered via an eyelid wipe. Hear Dr. Houman D. Hemmati walk through the study's design, its findings on safety and efficacy, and the next stImplementing ACIP's 2025 Flu Vaccine Guidelines Across Patient Populations
https://reachmd.com/programs/vaccination/implementing-acips-2025-flu-vaccine-guidelines-across-patient-populations/36263/As of July 2025, the Advisory Committee on Immunization Practices (ACIP) released new recommendations for influenza vaccination, stating that single-dose thimerosal-free formulations are now required for children up to 18, pregnant individuals, and all adults. While this new guidance may help streng